.png){kind=icon}
.png){kind=icon}
Return
Predictors of Clinical Trial Participation Among Patients with Head and Neck Cancer in the United States
.png){kind=icon}
PRE
AI
E
C
A
S
J
B
S
A
N
N
W
DOI：10.1016/j.ijrobp.2026.02.137.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Patient participation in clinical research is integral to refining treatment of head and neck cancer (HNC), a common and highly lethal malignancy in the United States and around the world. However, differences between clinical trial participants and the larger population afflicted by this disease may present obstacles to progress. Sociodemographic, cancer-specific, facility-specific, and treatment-related predictors of clinical trial participation were evaluated in a large cohort of patients with HNC.
Keywords:
Clinical trial participation
Head and neck cancer
Sociodemographic factors
Treatment-related predictors
Cancer-specific factors
Journal
I
IF:
0
Papers:
394
Citations:
0